An immunoinformatics approach for identification and characterization of T cell-mediated heterologous immunity between RNA viruses and allergens
Loading...
Files
Date
relationships.isAuthorOf
Publisher
Philipps-Universität Marburg
item.page.supervisor-of-thesis
Abstract
Asthma is one of the major chronic inflammatory disorders worldwide. Respiratory
virus infections and exposure to allergens are important risk factors for asthma development.
Our group previously demonstrated an influenza-mediated protective
effect over experimental asthma in a murine model, which was dependent on crossreactive
T effector memory cells. The hypothesis of this research work was that virus-
mediated heterologous immune response is a broadly applicable concept for
several respiratory viruses and environmental allergens. This immune response
may be mediated by cross-reactive virus-specific memory T cells, which react in a
T1-driven immune response upon allergen exposure. In order to test this hypothesis,
a comprehensive in-silico pipeline for prediction of potentially cross-reactive
T cell epitope pairs between several respiratory viruses and allergens was developed,
taking MHC binding affinity and sequence similarity of the T cell epitopes into
consideration. An additional scoring system further characterized and prioritized
the allergen counterpart based on clinical relevance and conservation criteria.
Mouse Balb/c MHC class I epitope pairs were validated for MHC stabilization in an
in-vitro assay and binder pairs were used for further ex-vivo and in-vivo experiments.
Using an RSV A2 infection model, ex-vivo T cell stimulation assays of lung
cells and splenocytes confirmed immunogenicity of the predicted virus peptides as
well as cross-reactivity of the corresponding allergen peptides. Additionally, dual
pentamer staining of lung cells of RSV-infected mice with the predicted candidate
pair RSV A2 L356-364 FYNSMLNNI/Asp f 4192-200 WYGNSALTI revealed virus- and allergen-
specific CD8+ T effector memory cells, as well as double positive T cells.
Based on this result and the fact that several predicted candidate pairs derived from
Aspergillus fumigatus (Asp f), mice were immunized with a pool of RSV A2-derived
peptides that were predicted to cross-react with Asp f-derived peptides. Ex-vivo
stimulation of splenocytes with the predicted Asp f-derived peptides resulted in increased
proliferation, activation and cytokine production of CD8+ T cells. Subsequently,
a potentially protective effect of RSV A2 infection towards development of
Asp f-induced experimental asthma was investigated. A preceding RSV infection resulted
in less eosinophils and T2 cytokines in the BAL of allergic asthmatic animals
compared to those without virus infection, as well as a trend for reduced abundance neutrophils and T2-biased CD8+ T cells in the lung. Additionally, lung histology sections
confirmed less mucus-producing goblet cells and inflammation.
In order to investigate the contribution of the predicted cross-reactive T cell
epitopes in the attenuation of the allergic asthmatic response, mice were immunized
with the predicted RSV-derived peptides and subsequently subjected to the Asp fmouse
model. These animals had lower numbers of eosinophils in the BAL, displayed
a trend for reduced IL5+ CD8+ T cells and increased abundance of IFNγ+ CD8+
T cells in the lung compared to allergic asthmatic mice without prior peptide immunization.
In addition to RSV A2, candidate epitope pairs for the virus strains of the seasonal
quadrivalent influenza vaccine 2019/2020 (QIV) were predicted and validated invitro.
A mouse model of influenza vaccination was established, inducing both humoral
response and virus-specific T cell response. Mice were vaccinated with the
QIV and ex-vivo stimulation of splenocytes with the predicted allergen peptides resulted
in increased induction of activated CD8+ CD69+ T cells compared to control
stimulation and mock animals. Subsequently, QIV immunization was combined with
an HDM-induced experimental asthma model and, similarly to the RSV/Asp f model,
hallmarks of allergic asthma were attenuated, including numbers of eosinophils,
lung inflammation and mucus production.
In summary, these data confirm virus-induced heterologous immune responses towards
environmental allergens, which result in attenuation of allergen-mediated experimental
asthma. Several epidemiologically relevant respiratory RNA viruses play
a role in this regard. A more extensive virus peptide pool may be needed to induce
the same degree of attenuation with peptide immunization versus virus infection.
Further experiments using human biomaterial for investigation of cross-reactive
T cell populations among asthmatic and healthy individuals who have or have not
been vaccinated against influenza or following specific virus infections would support
the translational potential of our findings. Evidence in this regard will have important
implications for future peptide vaccination strategies, inducing dual antiviral
and anti-allergic potential.
Review
Metadata
Contributors
Supervisor:
Dates
Created: 2022Issued: 2023-01-30Updated: 2023-01-30
Faculty
Medizin
Publisher
Philipps-Universität Marburg
Language
ger
Data types
DoctoralThesis
Keywords
Heterologe ImmunitätT cellsVirologieVirologyImmunologyT ZellenHeterologous immunityImmunologie
DFG-subjects
Heterologe ImmunitätRNA VirenKreuzreaktivitätT Zellen
DDC-Numbers
500
show more
Balz, Kathrin Jana: An immunoinformatics approach for identification and characterization of T cell-mediated heterologous immunity between RNA viruses and allergens. : Philipps-Universität Marburg 2023-01-30. DOI: https://doi.org/10.17192/z2022.0272.
License
This item has been published with the following license: In Copyright